TRG-200

N/A

Report date: 2026/02/15 20:00:16

Base Information

Drug NameTRG-200
Drug Alias NameIntravesical sustained-release oxybutynin formulation (Trigone Pharma)TRG-200
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTrigone Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTrigone Pharma Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Bladder, Overactive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A